FDA commish Hamburg looks to spur med-tech innovation

October 5, 2011 by MassDevice staff

FDA commissioner Dr. Margaret Hamburg

Dr. Margaret Hamburg, the head of the FDA, put out a blueprint for spurring innovation in the life sciences today, saying there aren't enough new products in the med-tech pipeline to suit her.

"The number of new products in the development pipeline is not where we would want it to be and it's not commensurate with the medical and public health need," Hamburg said during a conference call this afternoon.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.